(Q24202647)

1

0 references

Brian R Davidson

4

object named as

Brian R Davidson

0 references

Rahul S Koti

2

object named as

Rahul Koti

0 references

Giuseppe Fusai

3

object named as

Giuseppe Fusai

0 references

author name string

Brian R Davidson

Cochrane Database of Systematic Reviews

4

0 references

publication date

13 June 2012

0 references

published in

0 references

cites work

Role of octreotide in the prevention of postoperative complications following pancreatic resection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

The Potent Somatostatin Analogue Vapreotide Does Not Decrease Pancreas-Specific Complications After Elective Pancreatectomy: A Prospective, Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Role of somatostatin and somatostatin analogues in the treatment of gastrointestinal diseases: prevention of complications after pancreatic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Evaluation of lanreotide effects on human exocrine pancreatic secretion after a single dose: preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Current standards of surgery for pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Postoperative pancreatic fistula: an international study group (ISGPF) definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

The Clavien-Dindo classification of surgical complications: five-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Assessment of risk of bias in randomized clinical trials in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

A comparison of methods to detect publication bias in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Intention-to-treat analysis: implications for quantitative and qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Somatostatin analogues for pancreatic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Fibrin glue sandwich prevents pancreatic fistula following distal pancreatectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

[Natural history of the pancreatic stump after duodenopancreatectomy of the pancreatic head]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Does prophylactic octreotide benefit patients undergoing elective pancreatic resection?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Prospectively randomized trial using perioperative low dose octreotide to prevent organ related and general complications following pancreatic surgery and pancreatico-jejunostomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Prevention of postoperative complications following pancreatic surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Germany

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021

Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008370.PUB2

7 January 2021